Clinical Tools & Resources

Looking for information about clinical and diagnostic investigations appropriate for patients with possible cardiovascular related symptoms?

The Canadian Association of Radiologists supports your decision making by summarizing investigations indicated for cardiovascular related symptoms.

Searching for a guideline around lipid management in primary care?

The Patients, Experience, Evidence and Research (PEER) group created this guideline around lipids and the prevention and management of cardiovascular disease. Refer to this guideline when prescribing and managing lipid related therapy for your patients.

How should you prioritize alcohol abstinence when managing atrial fibrillation?

This PEER Tool for Practice provides the latest information to help determine prioritization of alcohol abstinence when managing atrial fibrillation. Read this article to get the latest evidence on alcohol use and atrial fibrillation.

Is it worthwhile using omega-3 derivatives, such as icosapent, when managing cardiovascular risk?

This PEER Tool for Practice summarizes the evidence on omega-3 derivatives and its impact on reducing cardiovascular risk. Read the article when looking for the evidence on icosapent and other omega-3 derivatives.

Want to know what the PEER evidence group decided as the top 5 Tools for Practice articles in 2020?

The PEER evidence group summarizes the top Tools for Practice evidence summaries into one place. Read five different clinical topic summaries in one article.

What is the efficacy of Sodium Glucose Transport Protein-2 (SGLT2) inhibitors in patients with systolic heart failure?

This PEER Tool for Practice outlines the evidence on SGLT2 inhibitors in the treatment of systolic heart failure. Read this article to see the impact of SGLT2 inhibitors in heart failure.

Is colchicine effective for secondary cardiovascular prevention?

This PEER Tool for Practice provides a review of cardiovascular prevention trials, and lists the major findings with respect to colchicine. Read this article if you have considered colchicine as a treatment for your cardiovascular patients.

Is exercise beneficial for patients with peripheral artery disease (PAD)?

This PEER Tool for Practice presents the available evidence that exercise therapy improves maximum walking distance and pain-free walking distance.

Which heart failure medications reduce death or hospitalization in patients?

This PEER Tool for Practice presents evidence from five systemic reviews in the last 5 years, that only mineralocorticoid receptor antagonists (MRA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce hospitalizations in patients with heart failure and ejection fraction of >40%. Other medications (CE inhibitors, ARBs, beta-blockers, and sacubitril-valsartan) were not found to reduce hospitalization or deaths. No medications were found to reduce mortality.